Pharmacology

Research from anesthesiology, pain and critical care journals, sourced from PubMed.

Sorted by publication date, not import date. Recent filters exclude papers with only a publication year; find those under All years.

AI-generated abstract summaries can contain errors. Verify findings against the original paper before applying them to patient care.

Last successful paper check: 16 Nov 2026 17:18 UTC. 0 newly discovered papers saved; these are not necessarily published today.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
RCT Anesthesiology Published 10 Nov 2026
Quality of Recovery After Primary Breast Cancer Surgery: A Randomized, Two-Centre, Triple-Blinded Trial Comparing Erector Spinae Plane Block and Intravenous Lidocaine Infusion Within a Multimodal Analgesia Framework.
AI-generated abstract summary · verify against the original paper
  • Randomized, triple-blinded, placebo-controlled two-centre trial of 80 adults undergoing primary breast cancer surgery, with or without axillary dissection.
  • Patients received either an ultrasound-guided erector spinae plane block (n=40) or intraoperative IV lidocaine infusion (n=40), both within a standardized multimodal analgesic protocol.
  • The 24-hour QoR15 score was 137.7 (SD 17.9) with ESPB versus 136.3 (SD 8.8) with IVLI, p=0.61.
  • Pain scores, opioid use and rescue analgesia were similarly low in both groups, and the authors suggest IVLI may be a pragmatic option when regional expertise is limited.
PubMed indexed 10 Nov 2026 Imported 11 Nov 2026 Sivakumar RK et al. Publisher PharmacologyRegional
Review J Pain Published 9 Nov 2026
Ketamine for co-occurring chronic pain and depression: A scoping review highlighting the dual-outcome evidence gap and its treatment and research implications.
AI-generated abstract summary · verify against the original paper
  • This PRISMA-ScR scoping review screened 2,187 records and included 12 studies of ketamine with pain and depression outcomes assessed longitudinally.
  • Eight studies enrolled chronic pain patients and four enrolled depression-primary populations, while acute, perioperative, perinatal, and cancer-related pain were excluded.
  • Most studies reported concurrent improvement in pain and depressive symptoms, but the abstract gives no pooled effect size.
  • The authors conclude that heterogeneity in populations, dosing, design, and comorbidity prevents inferring that depression modifies ketamine's analgesic effect, and call for randomized trials.
PubMed indexed 9 Nov 2026 Imported 10 Nov 2026 Asnes S et al. Publisher Chronic painPharmacology
Meta-analysis Eur J Anaesthesiol Published 3 Nov 2026
Sugammadex versus neostigmine for neuromuscular blockade reversal in adults: A systematic review and meta-analysis of randomised controlled trials.
AI-generated abstract summary · verify against the original paper
  • Systematic review and meta-analysis of 165 randomised trials, including 19,124 adults receiving rocuronium or vecuronium for elective procedures.
  • Sugammadex 2 mg/kg was compared with neostigmine 0.05 mg/kg for neuromuscular blockade reversal, though risk of bias across trials was generally unclear or high.
  • Sugammadex shortened time to a train-of-four ratio above 0.9 by 10.49 minutes (95% CI -11.90 to -9.08; moderate GRADE) and lowered the risk of at least one adverse event (RR 0.72, 95% CI 0.61 to 0.84).
  • The authors conclude sugammadex probably reverses blockade faster with fewer adverse events, including residual blockade, desaturation and bradycardia, though the evidence is rated moderate certainty.
PubMed indexed 3 Nov 2026 Imported 9 Nov 2026 Putzu A et al. Publisher Pharmacology
Review Eur Geriatr Med Published 30 Oct 2026
Effects of perioperative dexmedetomidine on postoperative delirium in older surgical patients: an updated meta-analysis of randomized controlled trials.
AI-generated abstract summary · verify against the original paper
  • Meta-analysis of 22 RCTs including 4161 older surgical patients under general anesthesia, searched across PubMed, Embase and CENTRAL through July 2026.
  • Compared perioperative intravenous dexmedetomidine with control for prevention of postoperative delirium, the primary outcome.
  • Dexmedetomidine reduced postoperative delirium (RR 0.56, 95% CI 0.47 to 0.66; P<0.00001; I² 24%) and PONV (RR 0.79, 95% CI 0.62 to 0.99; P=0.04).
  • Dexmedetomidine was associated with more intraoperative and postoperative bradycardia and more intraoperative hypotension.
PubMed indexed 31 Oct 2026 Imported 9 Nov 2026 Shi CG et al. Publisher NeuroPerioperative medicinePharmacology
RCT Br J Anaesth Published 29 Oct 2026
Effect of remimazolam versus propofol anaesthesia on postoperative delirium in neurovascular surgery: a randomised noninferiority trial.
AI-generated abstract summary · verify against the original paper
  • Single-centre, double-blind randomised noninferiority trial of 686 adults having elective neurovascular surgery, analysed as a modified intention-to-treat population.
  • Patients received remimazolam-based TIVA with flumazenil reversal at emergence or propofol-based TIVA, both with remifentanil.
  • Postoperative delirium within 5 days occurred in 12.8% (44/344) with remimazolam and 10.8% (37/342) with propofol; risk difference 1.97 percentage points (95% CI -2.85 to 6.80).
  • Remimazolam met the prespecified noninferiority criterion, and that group had less intraoperative hypotension below a MAP of 65 mm Hg and more operating-room extubation.
PubMed indexed 29 Oct 2026 Imported 9 Nov 2026 Kim J et al. Publisher NeuroPharmacology
Review Rev Esp Anestesiol Reanim (Engl Ed) Published 29 Oct 2026
Dexmedetomidine versus propofol for the prevention of postoperative delirium in older adults undergoing regional anaesthesia: A systematic review and meta-analysis.
AI-generated abstract summary · verify against the original paper
  • Systematic review and meta-analysis of five randomized trials, totaling 1613 adults aged 60 or older having surgery under regional anesthesia.
  • Compared intraoperative dexmedetomidine with propofol, with delirium assessed using CAM or CAM-ICU.
  • Delirium occurred in 7.7% of dexmedetomidine patients versus 16.7% with propofol (RR 0.48, 95% CI 0.36-0.64; P < .001), with low heterogeneity (I² = 13.4%).
  • The authors conclude dexmedetomidine is associated with less postoperative delirium, and they rated the certainty of evidence as moderate by GRADE.
PubMed indexed 29 Oct 2026 Imported 9 Nov 2026 Estefó M et al. Publisher NeuroPharmacologyRegional
RCT Drug Des Devel Ther Published 27 Oct 2026
Effect of Preoperative Intranasal Dexmedetomidine on Postoperative Myocardial Injury in Patients Undergoing Coronary Artery Bypass Grafting.
AI-generated abstract summary · verify against the original paper
  • Randomized, double-blind, placebo-controlled single-center trial of 70 patients undergoing on-pump CABG.
  • Patients received intranasal dexmedetomidine 1 μg/kg or saline on the night before surgery and again 30 minutes before induction.
  • At 24 hours, estimated marginal mean hs-cTnT was 170.29 vs 357.29 ng/L (P < 0.001) favoring dexmedetomidine; CK-MB was also lower.
  • Sleep quality scores were higher and postoperative delirium was lower (14.3% vs 37.1%; P = 0.029), but the authors call the findings preliminary.
PubMed indexed 1 Nov 2026 Imported 9 Nov 2026 Li Q et al. Publisher CardiacPerioperative medicinePharmacology
Article Anesthesiology Published 23 Oct 2026
Role of Ventral Tegmental Area Dopamine Neurons in Emergence from Dexmedetomidine, Fentanyl, and Ketamine Anesthesia in Rats.
AI-generated abstract summary · verify against the original paper
  • Randomized block study in adult Sprague Dawley rats using viral constructs to express channelrhodopsin or a control protein in tyrosine hydroxylase-positive VTA neurons.
  • Optogenetic stimulation of these neurons was tested during sevoflurane, dexmedetomidine, fentanyl, and ketamine unconsciousness, with and without light.
  • Photostimulation restored sevoflurane-anesthetized righting at a median 4.7 min (95% CI, 2.6 to 6.4); after dexmedetomidine, hazard ratio 27.7 (95% CI, 2.7 to 287.1; P = 0.0053).
  • Effects were agent specific: no change after fentanyl, a modest delay in ketamine emergence, and the authors suggest distinct and sometimes opposing pathways shape the role.
PubMed indexed 31 Aug 2026 Imported 9 Nov 2026 Obert DP et al. Publisher Pharmacology
Article J Cardiothorac Vasc Anesth Published 22 Oct 2026
Safety and Efficacy of Low-Dose Ketamine Infusion for Pain Management after Cardiac Surgery:A Single Center Pre-Post Analysis.
AI-generated abstract summary · verify against the original paper
  • Single-center retrospective before-and-after cohort with propensity matching in a cardiothoracic ICU compared 122 ketamine and 122 control patients after cardiac surgery.
  • Patients on an ERAS pathway received a continuous low-dose ketamine infusion (0.1-0.3 mg/kg/h) or no ketamine as the control.
  • Cumulative opioid use over POD0-2 was lower with ketamine (30 vs 52.5 MME; p = 0.003), and time to first analgesic was longer (7.4 vs 4.5 h; p < 0.001).
  • No hallucinations were seen and urinary retention fell (9.8% vs 34%; p < 0.001), and the authors describe ketamine as a safe adjunct.
PubMed indexed 13 Nov 2026 Imported 14 Nov 2026 Hall J et al. Publisher CardiacPerioperative medicinePharmacology
Review Front Pediatr Published 21 Oct 2026
Dose- and endpoint-dependent effects of perioperative esketamine in children: evidence from a targeted review.
AI-generated abstract summary · verify against the original paper
  • This mini review synthesizes a targeted search of pediatric esketamine studies covering analgesia, sedation, propofol injection pain, and emergence delirium or agitation.
  • Randomized trials and meta-analyses generally report fewer emergence delirium or agitation events after low intravenous esketamine doses, mostly during sevoflurane adenotonsillectomy.
  • Direct dose-comparison evidence in that setting shows increasing benefit up to 0.5 mg/kg intravenously, with no upper efficacy or safety boundary identified.
  • The authors conclude that 0.2-0.5 mg/kg IV was the best-studied range for emergence prevention, not a validated therapeutic window, and call for direct dose-timing trials.
PubMed indexed 5 Nov 2026 Yang Y et al. Publisher NeuroPediatricPerioperative medicinePharmacology
RCT Pain Med Published 19 Oct 2026
Perineural or intravenous dexamethasone for adductor canal and iPACK blocks in total knee arthroplasty: A randomised trial.
AI-generated abstract summary · verify against the original paper
  • Randomised, quadruple-blind trial of 90 patients aged 65-100 undergoing primary total knee arthroplasty, comparing dexamethasone adjuncts to adductor canal and iPACK blocks.
  • Perineural dexamethasone (4 mg total, 2 mg per block) with ropivacaine was compared with intravenous dexamethasone 4 mg and with placebo.
  • Median time to first rescue opioid was 4.5 h with placebo, 13.9 h with IV dexamethasone and 18.5 h with perineural dexamethasone (log-rank p < 0.001).
  • Perineural dexamethasone produced lower opioid use than IV at later timepoints, and no motor weakness or nerve injury was reported.
PubMed indexed 19 Oct 2026 Imported 9 Nov 2026 Reysner T et al. Publisher Chronic painPharmacologyRegional